Cargando…

Consensus molecular subtypes classification of colorectal cancer as a predictive factor for chemotherapeutic efficacy against metastatic colorectal cancer

The consensus molecular subtypes (CMS) classification is one of the most robust colorectal cancer (CRC) classifications based on comprehensive gene expression profiles. This study aimed to clarify whether the CMS is a predictive factor for therapeutic effects of standard chemotherapies for metastati...

Descripción completa

Detalles Bibliográficos
Autores principales:	Okita, Akira, Takahashi, Shin, Ouchi, Kota, Inoue, Masahiro, Watanabe, Mika, Endo, Mareyuki, Honda, Hiroshi, Yamada, Yasuhide, Ishioka, Chikashi
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Impact Journals LLC 2018
Materias:	Research Paper
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5922348/ https://www.ncbi.nlm.nih.gov/pubmed/29721154 http://dx.doi.org/10.18632/oncotarget.24617

Ejemplares similares

Advanced colorectal cancer subtypes (aCRCS) help select oxaliplatin‐based or irinotecan‐based therapy for colorectal cancer
por: Takahashi, Shin, et al.
Publicado: (2021)

microRNA-193a-3p is specifically down-regulated and acts as a tumor suppressor in BRAF-mutated colorectal cancer
por: Takahashi, Hidekazu, et al.
Publicado: (2017)

DNA methylation status as a biomarker of anti‐epidermal growth factor receptor treatment for metastatic colorectal cancer
por: Ouchi, Kota, et al.
Publicado: (2015)

A modified MethyLight assay predicts the clinical outcomes of anti‐epidermal growth factor receptor treatment in metastatic colorectal cancer
por: Ouchi, Kota, et al.
Publicado: (2022)

The Consensus Molecular Subtypes of Colorectal Cancer
por: Guinney, Justin, et al.
Publicado: (2015)

Antibiotics Improve the Treatment Efficacy of Oxaliplatin-Based but Not Irinotecan-Based Therapy in Advanced Colorectal Cancer Patients
por: Imai, Hiroo, et al.
Publicado: (2020)

Altered gene expression due to aberrant DNA methylation correlates with responsiveness to anti‐EGFR antibody treatment
por: Otsuki, Yasufumi, et al.
Publicado: (2022)

Metastatic heterogeneity of the consensus molecular subtypes of colorectal cancer
por: Eide, Peter W., et al.
Publicado: (2021)

Investigation of colorectal cancer in accordance with consensus molecular subtype classification
por: Sawayama, Hiroshi, et al.
Publicado: (2020)

Implications of Intratumor Heterogeneity on Consensus Molecular Subtype (CMS) in Colorectal Cancer
por: Chowdhury, Saikat, et al.
Publicado: (2021)

MmCMS: mouse models’ consensus molecular subtypes of colorectal cancer
por: Amirkhah, Raheleh, et al.
Publicado: (2023)

Consensus molecular subtype classification of colorectal adenomas
por: Komor, Malgorzata A, et al.
Publicado: (2018)

Different impacts of TP53 mutations on cell cycle-related gene expression among cancer types
por: Sasaki, Keiju, et al.
Publicado: (2023)

The G8 screening tool enhances prognostic value to ECOG performance status in elderly cancer patients: A retrospective, single institutional study
por: Takahashi, Masahiro, et al.
Publicado: (2017)

Context matters—consensus molecular subtypes of colorectal cancer as biomarkers for clinical trials
por: Fontana, E, et al.
Publicado: (2019)

Distinct gut microbiome patterns associate with consensus molecular subtypes of colorectal cancer
por: Purcell, Rachel V., et al.
Publicado: (2017)

Consensus Molecular Subtypes (CMS) in Metastatic Colorectal Cancer - Personalized Medicine Decision
por: Rebersek, Martina
Publicado: (2020)

YAP/TAZ Signalling in Colorectal Cancer: Lessons from Consensus Molecular Subtypes
por: Mouillet-Richard, Sophie, et al.
Publicado: (2020)

Consensus molecular subtypes of colorectal cancer in clinical practice: A translational approach
por: Valenzuela, Guillermo, et al.
Publicado: (2021)

Genomic landscape and expression profile of consensus molecular subtype four of colorectal cancer
por: Lu, Yujie, et al.
Publicado: (2023)

Tumor suppressor miR‐193a‐3p enhances efficacy of BRAF/MEK inhibitors in BRAF‐mutated colorectal cancer
por: Hiraide, Sakura, et al.
Publicado: (2021)

Chemotherapeutic treatment of colorectal cancer in pregnancy: case report
por: Makoshi, Ziyad, et al.
Publicado: (2015)

Antibiotic therapy augments the efficacy of gemcitabine-containing regimens for advanced cancer: a retrospective study
por: Imai, Hiroo, et al.
Publicado: (2019)

CMScaller: an R package for consensus molecular subtyping of colorectal cancer pre-clinical models
por: Eide, Peter W., et al.
Publicado: (2017)

Study protocol of the TRICOLORE trial: a randomized phase III study of oxaliplatin-based chemotherapy versus combination chemotherapy with S-1, irinotecan, and bevacizumab as first-line therapy for metastatic colorectal cancer
por: Komatsu, Yoshito, et al.
Publicado: (2015)

Neoantigen-specific immunity in low mutation burden colorectal cancers of the consensus molecular subtype 4
por: van den Bulk, Jitske, et al.
Publicado: (2019)

Identification of Gene Co-Expression Networks Associated with Consensus Molecular Subtype-1 of Colorectal Cancer
por: Nunez, Sha’Kayla K., et al.
Publicado: (2021)

Clinical Value of Consensus Molecular Subtypes in Colorectal Cancer: A Systematic Review and Meta-Analysis
por: ten Hoorn, Sanne, et al.
Publicado: (2021)

The KRAS-Mutant Consensus Molecular Subtype 3 Reveals an Immunosuppressive Tumor Microenvironment in Colorectal Cancer
por: Tanjak, Pariyada, et al.
Publicado: (2023)

Identifying essential genes in genome-scale metabolic models of consensus molecular subtypes of colorectal cancer
por: Cheng, Chao-Ting, et al.
Publicado: (2023)

Survival after initial lung metastasectomy for metastatic colorectal cancer in the modern chemotherapeutic era
por: Yokoyama, Shintaro, et al.
Publicado: (2017)

Role of Ginseng, Quercetin, and Tea in Enhancing Chemotherapeutic Efficacy of Colorectal Cancer
por: Zhao, Linxian, et al.
Publicado: (2022)

Phase II study of biweekly cetuximab plus mFOLFOX6 or mFOLFIRI as second-line treatment for metastatic colorectal cancer and exploratory analysis of associations between DNA methylation status and the efficacy of the anti-EGFR antibody: T-CORE1201
por: Takahashi, Shin, et al.
Publicado: (2023)

Image-based consensus molecular subtype (imCMS) classification of colorectal cancer using deep learning
por: Sirinukunwattana, Korsuk, et al.
Publicado: (2021)

Classification of patients with metastatic colorectal cancer into consensus molecular subtypes into real-world: A pilot study
por: González-Montero, Jaime, et al.
Publicado: (2023)

Promotion of the Warburg effect is associated with poor benefit from adjuvant chemotherapy in colorectal cancer
por: Kitazawa, Masashi, et al.
Publicado: (2020)

Mucinous Subtype in Patients With Colorectal Cancer
por: Kim, Hyung Jin
Publicado: (2017)

Clinical Relevance of Myopenia and Myosteatosis in Colorectal Cancer
por: Okugawa, Yoshinaga, et al.
Publicado: (2022)

Immunological landscape of consensus clusters in colorectal cancer
por: Karpinski, Pawel, et al.
Publicado: (2017)

Characterization of the consensus mucosal microbiome of colorectal cancer
por: Zhao, Lan, et al.
Publicado: (2021)

Cannot write session to /tmp/vufind_sessions/sess_dh5ffaho66m870flghb7pdgja9